News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
(EMAILWIRE.COM, June 21, 2011 ) New York, NY – The Topamax birth defects attorneys working with Class Action.org are alerting consumers to a March FDA announcement regarding the increased risk of oral clefts in children born to mothers taking Topamax while pregnant. According to the Topamax birth defects announcement, new data revealed that 1.4% of infants exposed to the drug or its generic topiramate while in the womb developed oral clefts, compared to only .38 to .55% of infants exposed to other anti-epileptic drugs. To learn more about the Topamax birth defects risk and to receive a free evaluation of your claim, visit http://www.classaction.org/topamax.html.
According to the FDA, Topamax birth defects may include cleft lips and cleft palates, which develop when parts of the lip or palate do not fuse together properly. Topamax clefts can range from a small notch in the lip to a split which extends into the nose and palate. In addition to cosmetic problems, Topamax birth defects can also interfere with eating and speaking. Depending on the extent of the Topamax cleft lip or palate, one or more surgeries may be required.
Due to the risk of Topamax birth defects, the FDA will strengthen the warning on the epilepsy and migraine medication. Topamax was originally classified under Pregnancy Category C; this means that animal studies indicated a potential risk to a fetus, but adequate human research was not yet available. Due to the Topamax birth defects risk, however, the drug will now be reclassified. Topamax is now found under Pregnancy Category D, indicating that there is positive evidence of risk to a human fetus based on human studies; however, the drug may still be prescribed to pregnant women in some cases, should its benefits outweigh its risks.
Women who delivered children with Topamax birth defects after taking the drug during pregnancy may have legal recourse. Potentially, a Topamax lawsuit would seek compensation for medical bills and other damages resulting from the childÂ’s Topamax cleft lip or cleft palate. To learn more about Topamax birth defects and your eligibility for legal action, visit Class Action.org today and complete the free case review form. The Topamax birth defect lawyers working with the site are providing this online evaluation at no cost and remain committed to protecting the rights of mothers who delivered children with Topamax birth defects after taking the drug while pregnant.
About Class Action.org
Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:
